Fresenius SE & Co. (OTCMKTS:FSNUY) KGaA is a Germany-based global health care group that develops and provides products, services and technologies for hospitals, clinics and patients. The company’s activities are focused primarily on health care products and therapies, as well as the operation of hospitals and other medical facilities.
Fresenius Kabi, one of the company’s core businesses, supplies medicines and therapies for critically and chronically ill patients, including intravenous drugs, clinical nutrition, infusion therapies, medical devices and related services. Fresenius also operates hospitals in Germany through its Helios division, which provides inpatient and outpatient medical care through a network of acute-care and rehabilitation facilities.
Fresenius traces its origins to the Hirsch Pharmacy in Frankfurt, Germany, which was acquired by the Fresenius family in the 18th century. Over time, the business developed into an international health care company serving customers and patients across Europe, North America, Latin America, Asia and other global markets. Fresenius Medical Care, historically associated with the group’s dialysis business, has been managed as a separate company following Fresenius’ deconsolidation of its controlling interest.
Fresenius SE & Co. KGaA is managed by Chief Executive Officer Michael Sen. The company is headquartered in Bad Homburg vor der Höhe, Germany.
